Moneycontrol PRO
you are here: HomeNewsTrendsHealth

India overtakes US in total number of vaccines administered: Govt

While India launched the COVID-19 vaccination drive on January 16, and has administered over 32.36 crore doses till date, the US which started its inoculation drive on December 14, 2020 has given over 32.33 crore doses.

June 28, 2021 / 02:30 PM IST
(Representative image: Reuters)

(Representative image: Reuters)

India has overtaken the US in the total number of COVID-19 vaccine doses administered so far, the Union Health Ministry said on Monday.

While India launched the COVID-19 vaccination drive on January 16, and has administered over 32.36 crore doses till date, the US which started its inoculation drive on December 14, 2020 has given over 32.33 crore doses.

"India achieves another milestone in COVID-19 vaccination and overtakes USA in total number of COVID-19 vaccine doses administered," the ministry said.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

India’s cumulative vaccination coverage exceeded 32.36 crores on Sunday. A total of 32,36,63,297 vaccine doses have been administered through 43,21,898 sessions, as per the provisional report till 7 am on Monday, the ministry said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

It said 17,21,268 vaccine doses were administered in the last 24 hours.

According to the data, so far 1,01,98,257 healthcare workers have taken the first dose while 72,07,617 have taken the second dose.

As many as 1,74,42,767 frontline workers have received the first dose while 93,99,319 have taken the second dose. In the 18-44 age group, 8,46,51,696 individuals have taken then first dose, while 19,01,190 have received the second dose.

In the 45-59 age group, 8,71,11,445 people have been administered the first dose, while 1,48,12,349 have taken the second dose.

Besides, 6,75,29,713 people aged above 60 years have received the first dose, while, 2,34,08,944 have taken the second dose.

The new phase of universalization of COVID-19 vaccination commenced from June 21.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jun 28, 2021 02:30 pm
Sections
ISO 27001 - BSI Assurance Mark